company background image
600535 logo

Tasly Pharmaceutical Group SHSE:600535 Stock Report

Last Price

CN¥16.13

Market Cap

CN¥24.4b

7D

-7.9%

1Y

17.7%

Updated

25 Mar, 2024

Data

Company Financials +

Tasly Pharmaceutical Group Co., Ltd

SHSE:600535 Stock Report

Market Cap: CN¥24.4b

600535 Stock Overview

Tasly Pharmaceutical Group Co., Ltd engages in the pharmaceutical business in China and internationally.

600535 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth1/6
Past Performance4/6
Financial Health6/6
Dividends4/6

Tasly Pharmaceutical Group Co., Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Tasly Pharmaceutical Group
Historical stock prices
Current Share PriceCN¥16.13
52 Week HighCN¥18.00
52 Week LowCN¥12.88
Beta0.40
1 Month Change0.50%
3 Month Change-3.36%
1 Year Change17.65%
3 Year Change21.46%
5 Year Change-32.37%
Change since IPO380.26%

Recent News & Updates

Does Tasly Pharmaceutical Group (SHSE:600535) Have A Healthy Balance Sheet?

Mar 15
Does Tasly Pharmaceutical Group (SHSE:600535) Have A Healthy Balance Sheet?

Recent updates

Does Tasly Pharmaceutical Group (SHSE:600535) Have A Healthy Balance Sheet?

Mar 15
Does Tasly Pharmaceutical Group (SHSE:600535) Have A Healthy Balance Sheet?

Shareholder Returns

600535CN PharmaceuticalsCN Market
7D-7.9%-1.6%-0.03%
1Y17.7%-8.6%-14.2%

Return vs Industry: 600535 exceeded the CN Pharmaceuticals industry which returned -8.6% over the past year.

Return vs Market: 600535 exceeded the CN Market which returned -14.2% over the past year.

Price Volatility

Is 600535's price volatile compared to industry and market?
600535 volatility
600535 Average Weekly Movement5.7%
Pharmaceuticals Industry Average Movement6.9%
Market Average Movement8.1%
10% most volatile stocks in CN Market11.3%
10% least volatile stocks in CN Market5.1%

Stable Share Price: 600535 has not had significant price volatility in the past 3 months.

Volatility Over Time: 600535's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19949,183Jing Suhttps://www.taslypharma.com

Tasly Pharmaceutical Group Co., Ltd engages in the pharmaceutical business in China and internationally. It provides cardiovascular, anti-tumor, cold and fever, liver disease treatment, and other disease solutions. Tasly Pharmaceutical Group Co., Ltd was founded in 1994 and is based in Tianjin, China.

Tasly Pharmaceutical Group Co., Ltd Fundamentals Summary

How do Tasly Pharmaceutical Group's earnings and revenue compare to its market cap?
600535 fundamental statistics
Market capCN¥24.44b
Earnings (TTM)CN¥1.12b
Revenue (TTM)CN¥9.03b

21.4x

P/E Ratio

2.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600535 income statement (TTM)
RevenueCN¥9.03b
Cost of RevenueCN¥3.12b
Gross ProfitCN¥5.91b
Other ExpensesCN¥4.79b
EarningsCN¥1.12b

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Apr 16, 2024

Earnings per share (EPS)0.75
Gross Margin65.47%
Net Profit Margin12.40%
Debt/Equity Ratio26.5%

How did 600535 perform over the long term?

See historical performance and comparison

Dividends

2.0%

Current Dividend Yield

44%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.